SKYE
Skye BioscienceFNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-02
+
Peers tracked
8
U.S. public peers
Grade Position
Below peers
vs peer average
SKYE vs peer average
29/100
SKYE vs. peer average (F vs. D)
Grade spread
B 2 · D 2 · F 2
Graded peers loaded
Coverage
8 graded
100% of tracked
Peer overview
PLRZ is the first available peer comparator.
Same sector: Pharmaceuticals, Biotechnology & Life Sciences · Cap $25.12M
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
SKYE
Skye Bioscience
PLRZ
Polyrizon
Grade
F
N/A
Momentum
6
96
Value
59
-
Sentiment
-
-
Setup Bias
Net Neutral
-
Market Cap
-
-
Posture
Defensive
Unrated
Grade position vs PLRZ
SKYE / PLRZ
Grade Position
Below peers
SKYE vs. peer average (F vs. D)
29/100
Momentum
6
PLRZValue
59
-Sentiment
-
-Rotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs SKYE
PLRZ is the first peer returned for this comparison set.

